TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Medicinal Genomics

FEBRUARY 8, 2024

The subsequent investigation did not determine a definitive cause for the condition; however, the report did mention investigators tested the air for levels of endotoxin, “a pro-inflammatory contaminant associated with gram-negative bacterial growth on organic materials such as cannabis flower”.

Treatment 98

Treatment Dispensary Safety Cannabis 98

The Joint Blog

APRIL 17, 2020

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MMJ Recs

DECEMBER 20, 2023

The establishment of medical marijuana dispensaries in Virginia represents a progressive approach to healthcare, offering patients alternative treatment options for various medical conditions. Patients diagnosed with specific medical conditions are eligible to participate in the state’s medical cannabis program.

Dispensary 52

Dispensary Marijuana Strains Patients 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 96

Medicine Treatment Patients Data 96

FloridaMarijuana.net

JULY 8, 2018

The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions. Food and Drug Administration.

Strains 190

Strains Indica Hybrid Research and Development 190

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

TheAnswerPage

AUGUST 4, 2021

Efficacy and safety of add-on cannabidiol (CBD) to treat seizures associated with Lennox Gastaut Syndrome (LGS) was demonstrated in two randomized controlled trials (RCTs). 366 patients enrolled in a long-term open-label extension trial. Have the long-term effects of CBD use to treat the drug resistant seizures of LGS been evaluated?

Safety 52

Safety Patients Events CBD 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JUNE 23, 2021

Patient-reported outcomes. During ICRS2021, Sapphire Medical presented data from patients treated with medical cannabis. Across all patients, findings are reported in health-related quality of life as well as within specific conditions such as pain, anxiety, and palliative care. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

The Cannigma

OCTOBER 21, 2021

Still, many patients report that cannabis helps them to feel more in control of their symptoms, leading to important questions. Attention deficit hyperactivity disorder, or ADHD, is a condition characterized by behavioral symptoms such as inattentiveness, hyperactivity, impulsiveness. Can cannabis help with ADHD? What is ADHD?

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

Cannabis Law Report

SEPTEMBER 22, 2022

SB 1186– Medicinal Cannabis Patients’ Right of Access Act. The bill’s author, Senator Scott Weiner, states this bill is a victory for seniors living with chronic illness, and will both improve patient access and help fill voids throughout the state where no cannabis license types have been authorized.

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

DECEMBER 3, 2021

An analysis from continuous EEG recordings in 17 patients enrolled in the Phase 2 refractory status epilepticus (RSE) study demonstrated a substantial increase in the alpha/delta ratio immediately after the start of IV ganaxolone in 75% of patients. in patients continuing ganaxolone (n=38) and 33.3%

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Medicinal Genomics

JUNE 18, 2020

This assay should in no way be construed to assume that cannabis patients are at risk or that access to medical cannabis should be curtailed. . However, a proactive approach to testing for SARs-CoV-2 in the cannabis supply chain is the only way to test that hypothesis, and thus ensure patient safety and the financial survival of our industry.

Supply Chain 97

Supply Chain Patients Medicine Hemp 97

Veriheal

MARCH 18, 2021

Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment. The team made use of a “cross-species” approach in order to deepen the understanding of Alzheimer’s disease as well as on the feline cognitive decline, thus benefiting “patients of all species”. Why Aging Cats?

CBD 82

CBD Research and Development Pets Treatment 82

NORML

FEBRUARY 1, 2019

And officials in San Francisco, California are considering a proposal to allow marijuana to be socially consumed and sold at temporary events. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. CA resident? CA resident? Connecticut. CT resident?

Legislation 164

Legislation Decriminalization Access Patients 164

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Doctors and patients had to register on the Compassionate Use Registry , an online database maintained by the Florida Department of Health.

Law 126

Law Marijuana Patients Treatment 126

MMJ Recs

JUNE 25, 2021

On April 17, 2016, Pennsylvania’s governor legalized the use of medical marijuana in the state, and from February 15 th , 2018, those with a need for medical marijuana because of various health conditions were able to purchase and use cannabis legally. Getting a job with a medical card in Pennsylvania.

Conditions 52

Conditions Law Marijuana Events 52

Cannabis Law Report

OCTOBER 20, 2021

This is now the third time in the last 12 months there’s been a major event around extraction in Los Angeles. Business where fire occurred was legal, but the extraction operation had not gone through the permit and safety process. Two proved to be in critical condition and the other in serious condition.

Extraction 52

Extraction Hemp Safety Conditions 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen.

CBD 98

CBD THC Conditions Medicine 98

Kind Meds (Cannabis Education Blog)

MARCH 21, 2020

Many of our Medical Marijuana patients are wondering what, if any, changes are taking place over here at Kind Meds. Dear Kind Meds Patients, Many states across the United States have issued stay-at-home orders due to the COVID-19 virus. COVID-19 Safety Precautions for our Patients: Kind Meds is a Medical Cannabis Dispensary.

Dispensary 52

Dispensary Patients Safety Tincture 52

Puff Puff Post

MARCH 10, 2020

InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

JUNE 16, 2021

With increased capacity to screen patients, on a genetic basis, for underlying psychiatric disorders prior to undertaking PAP, Entheon is furthering its commitment toward safety and predictability in psychedelic therapies while aggregating data that can be used to determine which psychedelic molecules are best-suited for a particular patient.”

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

JANUARY 23, 2022

Events like these afford us a glimpse into the future of research and medicine in this field. GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. and 13.4%, respectively. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Cannabis Law Report

MAY 19, 2022

FDA states it has serious safety concerns with delta-8 THC. FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. FDA considers delta-8 THC to pose serious health and safety risks. FDA Warning Letters. meat, milk, and eggs).

THC 52

THC CBD Food Pets 52

The Joint Blog

JUNE 28, 2019

The study, titled Safety and efficacy of medical cannabis in fibromyalgia, was published by the Journal of Clinical Medicine and was published online by the U.S. It was found that 81% of participants reported “at least moderate improvement in their condition”, and this occurred “without experiencing serious adverse events.

Therapy 44

Therapy Chronic Pain Treatment Marijuana 44

Cannabis Law Report

OCTOBER 6, 2021

Matt Stang , co-founder and CEO of Delic Corp, stated, “Never before has a lab been authorized to test psychedelic compounds such as MDMA and LSD with the opportunity to create new medicines for the millions suffering from debilitating conditions like depression, anxiety, PTSD and Parkinson’s disease.

Research and Development 52

Research and Development Extraction Treatment Safety 52

CannaMD

DECEMBER 9, 2020

Noting that the effects of oral administration of cannabis (edibles) can be less predictable that smoked or vaporized administration of products with similar levels of specific cannabinoids, the AHA cautions: Patients must be made aware that the onset of effects begins within 30 minutes to ?1 ACUTE EFFECTS OF MARIJUANA.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Puff Puff Post

MARCH 19, 2020

Planet 13 will continue to ensure that customers and patients who rely on cannabis to manage their daily health and wellness needs have access. The Company’s staff has undergone extensive health and safety training. The Company’s staff has undergone extensive health and safety training.

Dispensary 72

Dispensary Safety Events Business 72

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JULY 7, 2021

We remain encouraged as we continue our evaluations of MYMD-1 for efficacy and safety – especially as studies continue to suggest we may be able to address many of the concerns that are associated with the current drugs on the market today in these disease areas.”. President, Director and Chief Medical Officer of MyMD. “We 646) 421-9523.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Veriheal

APRIL 14, 2022

The development of a medically-authorized supply chain will be overseen by the National Agency for the Safety of Medicines and Health Products (ANSM). The pilot program, which involves participation from approximately 3,000 patients who suffer from debilitating conditions, extends until March 2023.

Cultivation 52

Cultivation Supply Chain Research and Development Programs 52